Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant.

Ayalew TefferiAnimesh PardananiKebede H Begna Aref A Al-Kali William Joseph HoganMark R LitzowRhett P KetterlingKaaren K Reichard Naseema Gangat

Published in: Blood cancer journal (2024)

Keyphrases

adverse drug

emergency department

electronic health record